• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Aplication of Theta Burst Transcranial Magnetic Stimulation Over Both Hemispheres on Acute Thrombotic Stroke Patient (P4.362)
Conclusions: This study suggest that early intervention on trombotic stroke using theta burst transcranial magnetic stimulation to both hemispheres improve recovery of motor function performance and is feasible for complementary therapy. Keywords : Theta Burst Stimulation, Transcranial Magnetic Stimulation, acute thrombotic stroke, motoricity indexDisclosure: Dr. Sugianto has nothing to disclose. Dr. Hasyim has nothing to disclose.
Source: Neurology - April 3, 2016 Category: Neurology Authors: Sugianto, P., Hasyim, H. Tags: Cerebrovascular Case Reports Source Type: research

Randomized Controlled Trial of CI Therapy for Progressive MS: Increased Real-World Function and Neuroplasticity on MRI (S23.007)
CONCLUSIONS: CI therapy appears to be efficacious for improving real-world arm use in progressive hemiparetic MS and significantly increases cortical grey matter structural plasticity. Together, these findings suggest that CI therapy, but not CAM, can counteract the progressive functional loss and CNS degeneration of progressive MS.Supported by: National MS Society grant RG 4221 and NIH grant HD061767.Disclosure: Dr. Mark has nothing to disclose. Dr. Taub has nothing to disclose. Dr. Uswatte has nothing to disclose. Dr. Cutter has received personal compensation for activities with Sanofi-Aventis Pharmaceuticals Inc., Cleve...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Mark, V., Taub, E., Uswatte, G., Cutter, G., Morris, D., McKay, S., Bowman, M., Haddad, M., Rickards, T., Sterling, C. Tags: MS and CNS Inflammatory Disease: Novel Therapeutics Source Type: research

Randomized Controlled Trial of CI Therapy for Progressive MS: Increased Real-World Function and Neuroplasticity on MRI (I7-1.008)
CONCLUSIONS: CI therapy appears to be efficacious for improving real-world arm use in progressive hemiparetic MS and significantly increases cortical grey matter structural plasticity. Together, these findings suggest that CI therapy, but not CAM, can counteract the progressive functional loss and CNS degeneration of progressive MS.Supported by: National MS Society grant RG 4221 and NIH grant HD061767.Disclosure: Dr. Mark has nothing to disclose. Dr. Taub has nothing to disclose. Dr. Uswatte has nothing to disclose. Dr. Cutter has received personal compensation for activities with Sanofi-Aventis Pharmaceuticals Inc., Cleve...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Mark, V., Taub, E., Uswatte, G., Cutter, G., Morris, D., McKay, S., Bowman, M., Haddad, M., Rickards, T., Sterling, C. Tags: Emerging Therapeutic Advances in Multiple Sclerosis Poster Presentations Source Type: research

Paradoxical Embolism in the Setting of Inferior Vena Cava Filter Removal (P1.283)
Conclusions:Although clinically relevant events secondary to IVC filter migration and fracture are rare, they can be life-threatening. Care should be taken when choosing to place these devices, and alternative therapies should be considered when possible. They should be removed when no longer needed, as fracture rates are increased with longer dwell times. Up to half of complications can be avoided with retrieval within 3 months.Disclosure: Dr. Yost has nothing to disclose. Dr. Klaas has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Yost, M., Klaas, J. Tags: Cerebrovascular Disease Case Reports I Source Type: research